Открыть главное меню
Главная
Случайная
Войти
Настройки
О hpluswiki
Отказ от ответственности
hpluswiki
Найти
Редактирование:
CD180
Внимание:
Вы не вошли в систему. Ваш IP-адрес будет общедоступен, если вы запишете какие-либо изменения. Если вы
войдёте
или
создадите учётную запись
, её имя будет использоваться вместо IP-адреса, наряду с другими преимуществами.
Анти-спам проверка.
Не
заполняйте это!
CD180 antigen precursor (Lymphocyte antigen 64) (Radioprotective 105 kDa protein) [LY64] [RP105] ==Publications== {{medline-entry |title=A novel B cell population revealed by a CD38/CD24 gating strategy: CD38(-)CD24 (-) B cells in centenarian offspring and elderly people. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/23129025 |abstract=The B cell arm of adaptive immunity undergoes significant modifications with age. Elderly people are characterized by impaired B cell responses reflected in a reduced ability to effectively respond against viruses and bacteria. Alterations of immunity with advancing age (immunosenescence) have been widely studied in centenarians who are considered a good example of successful aging. In recent years, attention has shifted to centenarian offspring (CO) as a model of people genetically advantaged for healthy aging and longevity. Here, we describe the preliminary characterization of a proposed new population of memory B cells, defined as CD19( )CD38(-)CD24(-), which we find at higher frequencies in the elderly but less so in CO than healthy age-matched random controls. In addition, we found a decreased expression of RP105 ([[CD180]]), a toll-like receptor-associated molecule, on these cells. [[CD180]] downregulation may potentially be a marker of immunosenescence. Moreover, we show that these CD19( )CD38(-)CD24(-) B cells produce [[TNF]] and hypothesize that their observed expansion in the elderly might contribute to the increased inflammatory status sometimes designated "inflamm-aging." |mesh-terms=* ADP-ribosyl Cyclase 1 * Adult * Aged * Aged, 80 and over * Aging * B-Lymphocytes * CD24 Antigen * Cytokines * Female * Humans * Immunity, Cellular * Longevity * Lymphocyte Activation * Male * Middle Aged * Parents * Reference Values |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776115 }} {{medline-entry |title=Pathogenesis of lupus-like nephritis through autoimmune antibody produced by [[CD180]]-negative B lymphocytes in NZBWF1 mouse. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/22387632 |abstract=Toll-like receptors appear to play an important role in the pathogenesis of lupus-like nephritis in mice. In human and mouse, [[CD180]] is a homologue of [[TLR4]]. In SLE patients, the number of [[CD180]]-negative B cells in peripheral blood changes in parallel with disease activity. In the present study using NZBWF1 mice, the population of splenic [[CD180]]-negative B cells increased with progression of renal lesions and aging. These cells produced both anti-dsDNA and histone antibodies; the peripheral blood levels of anti-dsDNA antibody increased markedly with aging. B cells infiltrating into renal lesions were [[CD180]]-negative and produced anti-dsDNA antibody. Considered together, these findings indicate that [[CD180]]-negative B cells contribute significantly to development of SLE-like morbidity in NZBWF1 mice by autoantibody production. |mesh-terms=* Aging * Animals * Antigens, CD * Autoantibodies * Autoimmune Diseases * Autoimmunity * B-Lymphocytes * Cells, Cultured * Female * Humans * Kidney * Lupus Nephritis * Mice * Mice, Inbred BALB C * Mice, Inbred NZB * Spleen |full-text-url=https://sci-hub.do/10.1016/j.imlet.2012.02.012 }}
Описание изменений:
Пожалуйста, учтите, что любой ваш вклад в проект «hpluswiki» может быть отредактирован или удалён другими участниками. Если вы не хотите, чтобы кто-либо изменял ваши тексты, не помещайте их сюда.
Вы также подтверждаете, что являетесь автором вносимых дополнений, или скопировали их из источника, допускающего свободное распространение и изменение своего содержимого (см.
Hpluswiki:Авторские права
).
НЕ РАЗМЕЩАЙТЕ БЕЗ РАЗРЕШЕНИЯ ОХРАНЯЕМЫЕ АВТОРСКИМ ПРАВОМ МАТЕРИАЛЫ!
Отменить
Справка по редактированию
(в новом окне)
Шаблон, используемый на этой странице:
Шаблон:Medline-entry
(
править
)